Bronchodilation due to administration of beta-agonists is specifically related to their action at the β2-adrenoceptors. The efficacy of β2-agonists for patients with asthma and COPD results from a direct relaxation of airway smooth muscle and a secondary reduction of inflammatory cell activation. [More…]
Home / ABA Keyword of the Day / Beta-agonist: Bronchodilation mechanism
